<?xml version="1.0" encoding="UTF-8"?>
<ref id="B38">
 <label>38</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Skalisz</surname>
    <given-names>L. L.</given-names>
   </name>
   <name>
    <surname>Beijamini</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Joca</surname>
    <given-names>S. L.</given-names>
   </name>
   <name>
    <surname>Vital</surname>
    <given-names>M. A. B. F.</given-names>
   </name>
   <name>
    <surname>Da Cunha</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Andreatini</surname>
    <given-names>R.</given-names>
   </name>
  </person-group>
  <article-title>Evaluation of the face validity of reserpine administration as an animal model of depression-Parkinson's disease association</article-title>
  <source>
   <italic>Progress in Neuro-Psychopharmacology and Biological Psychiatry</italic>
  </source>
  <year>2002</year>
  <volume>26</volume>
  <issue>5</issue>
  <fpage>879</fpage>
  <lpage>883</lpage>
  <pub-id pub-id-type="doi">10.1016/s0278-5846(01)00333-5</pub-id>
  <pub-id pub-id-type="other">2-s2.0-0036592361</pub-id>
  <pub-id pub-id-type="pmid">12369260</pub-id>
 </element-citation>
</ref>
